Ng Derry Minyao, Haleem Maria, Mamuchashvili Anny, Wang Kai-Yun, Pan Jin-Feng, Cheng Yue, Ma Qi
Translational Research Laboratory for Urology, The Key Laboratory of Ningbo City, Ningbo First Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
Department of Urology, Ningbo First Hospital, The Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, China.
Ther Adv Urol. 2021 Feb 24;13:1756287221993300. doi: 10.1177/1756287221993300. eCollection 2021 Jan-Dec.
Treatment of urolithiasis depends on several important factors which include stone location, size, composition, and patient symptoms. Although significant advancements have been made in the surgical management of urolithiasis in the last decade, pharmacotherapy which can prevent the formation of new stones and decrease the recurrence of urolithiasis has not experienced the same level of success. Currently, urolithiasis is regarded as a complicated syndrome that is determined by numerous factors, and any treatment plan for urolithiasis should be individualized while considering any potential damage arising from stone-forming factors. This review introduces the most popular methods currently used to evaluate urolithiasis and the pharmacotherapy of urolithiasis based on patient-specific factors.
尿石症的治疗取决于几个重要因素，包括结石位置、大小、成分和患者症状。尽管在过去十年中尿石症的外科治疗取得了重大进展，但能够预防新结石形成并降低尿石症复发率的药物治疗却没有取得同样的成功。目前，尿石症被视为一种由多种因素决定的复杂综合征，任何尿石症的治疗方案都应个体化，同时考虑结石形成因素可能造成的损害。本综述介绍了目前用于评估尿石症的最常用方法以及基于患者特定因素的尿石症药物治疗。
